⌘K

Login Start Free

Home/Filings/144/0002086827-26-000004

144//SEC Filing

Taysha Gene Therapies, Inc. 144

Accession 0002086827-26-000004

CIK 0002086827other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 8:04 PM ET

Size

4.8 KB

Accession

0002086827-26-000004

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

Haque-Ahmed Rumana

CIK 0002086827

Entity typeother

Related Parties

1

filerCIK 0002086827

Filing Metadata

Form type: 144
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 8:04 PM ET
Size: 4.8 KB

View on SEC.gov